Spravato (esketamine) Treatment Proven Effective for
Treatment-Resistant Depression

You may benefit from adding SPRAVATO® to your existing oral antidepressant if you’re an adult with major depressive disorder (MDD) who has had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD).

SPRAVATO® is the only FDA-approved nasal spray for TRD

  • SPRAVATO® is an NMDA receptor antagonist that is believed to work differently by acting on a pathway in the brain that affects glutamate

Reach out to our Spravato Administrator Today!

Watch Short Informational Videos on Spravato which answers your questions about:

  • What is treatment resistant depression?

  • What makes Spravato different from oral antidepressants?

  • What can I expect about my first treatments?

  • What does Spravato treat and what are the side effects?

  • Why is there an observation period after taking Spravato?

  • How often will I take Spravato?

  • How soon might I see improvement in Spravato